מוזוביל

Ülke: İsrail

Dil: İbranice

Kaynak: Ministry of Health

Aktif bileşen:

PLERIXAFOR 24 MG / 1.2 ML

Mevcut itibaren:

SANOFI - AVENTIS ISRAEL LTD

ATC kodu:

L03AX16

Farmasötik formu:

SOLUTION FOR INJECTION

Uygulama yolu:

S.C

Tarafından üretildi:

GENZYME CORPORATION, USA

Terapötik grubu:

PLERIXAFOR

Terapötik endikasyonlar:

Mozobil is indicated in combination with G-CSF to enhance mobilisation of haematopietic stem cells to the peripheral blood for collection and subsequent autologous transplantation in patients with lymphoma and multiple myeloma .

Yetkilendirme tarihi:

2010-02-01